Simultaneous presentations of deep vein thrombosis and cerebral sinus thrombosis in a case of primary antiphospholipid syndrome

Angiology

Volumn 59, Issue 6, 2009, Pages 765-768

  Sakamoto, Shingo ^a   Akutsu, Koichi ^a   Kawase, Kayoko ^a   Takada, Tatsuro ^a   Seyama, Hidenori ^a   Takahashi, Jun ^a   Miyamoto, Susumu ^a   Nonogi, Hiroshi ^a   Takeshita, Satoshi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Antiphospholipid syndrome; Cerebral sinus thrombosis; Deep vein thrombosis

Indexed keywords

HEPARIN; WARFARIN;

ABDUCENS NERVE PARALYSIS; ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CEREBRAL SINUS THROMBOSIS; DECOMPRESSION; DEEP VEIN THROMBOSIS; DISEASE EXACERBATION; DRUG SUBSTITUTION; ECHOGRAPHY; FEMORAL VEIN; HEADACHE; HUMAN; INFERIOR CAVA VEIN OBSTRUCTION; LIMB SWELLING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLEDEMA; SEROLOGY; SHUNTING;

ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; CEREBRAL ANGIOGRAPHY; DECOMPRESSION, SURGICAL; FEMORAL VEIN; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; SINUS THROMBOSIS, INTRACRANIAL; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VENOUS THROMBOSIS; VENTRICULOPERITONEAL SHUNT;

EID: 57749174046     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707309310     Document Type: Article

References (13)

1. Crowther MA, Ginsberg JS Antiphospholipid antibody syndrome. New York, NY: Marcel Dekker ; 2002.
2. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002 ; 346: 752-763.
3. Cunha LP, Goncalves AC, Moura FC, Monteiro MLR. Severe bilateral visual loss as the presenting sign of cerebral venous sinus thrombosis: case report. Arq Bras Oftalmol. 2005 ; 68: 533-537.
4. Owler BK, Parker G., Halmagyi GM, et al. Pseudotumor cerebri syndrome: venous sinus obstruction and its treatment with stent placement. J Neurosurg. 2003 ; 98: 1045-1055.
5. Cervera R., Asherson RA Clinical and epidemiological aspects in the antiphospholipid syndrome. Immunobiology. 2003 ; 207: 5-11.
6. McNeil HP, Chesterman CN, Krilis SA Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol. 1991 ; 49: 193-280.
7. Cervera R., Piette JC, Font J., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002 ; 46: 1019-1027.
8. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005 ; 352: 1791-1798.
9. Ferro JM, Canhao P., Stam J., et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004 ; 35: 664-670.
10. Crowther MA, Ginsberg JS, Julian J., et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 2003 ; 349: 1133-1138.
11. Asherson RA, Khamashta MA, Ordi-Ros J., et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore). 1989 ; 68: 366-374.
12. Mackworth-Young CG, Loizou S., Walport MJ Antiphospholipid antibodies and disease. Q J Med. 1989 ; 72: 767-777.
13. Canhao P., Falcao F., Ferro JM Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis. 2003 ; 15: 159-166.